Delivery Order SPE2DR25D7068-SPE2DR26F5BV1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Mupirocin 2% Ointment in 22-gram units, valued at $2,145.58. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 23, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.59 to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment in 22-gram units, with a completion date of September 8, 2025. This is a firm fixed price, non-set-aside delivery order issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen, headquartered...
- The Defense Logistics Agency awarded a $3,448.43 delivery order to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment (22 GM) on September 9, 2025, with completion expected by September 10, 2025. This firm fixed-price contract represents a non-set-aside, competitively awarded procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment in 22-gram units on November 6, 2025, with a ceiling value of $1,393.99 and a firm fixed price structure. The delivery order represents a non-competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999.99 billion value through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,837.43 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Mupirocin 2% Ointment in 22-gram units. This is a firm fixed price delivery order with no set-aside designation, completed under open competition. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 7, 2025. This delivery order represents a child contract...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Mupirocin 2% Ointment in 22-gram units, with a contract ceiling value of $5,614.00 and a firm fixed price. The award was competitively procured without set-aside designation and is scheduled for completion by August 22, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Mupirocin 2% Ointment in 22-gram units, with a ceiling value of $2,900.42. This firm fixed price delivery order, awarded on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a continuation of the company's role as a critical pharmaceutical supplier to federal medical procurement needs. The contract utilizes no set-aside designation and will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $1,061.31 to AmerisourceBergen Drug Corp for Mupirocin 2% Cream 15GM on September 8, 2025, with completion expected by September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and primary...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.97 to AmerisourceBergen Drug Corp for Mupirocin 2% Cream in 15-gram quantities. This competitively awarded, firm fixed-price delivery order was issued on August 29, 2025, with an ultimate completion date of September 2, 2025. The contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $1,542.84 to AmerisourceBergen Drug Corp for the supply of Mupirocin 2% Cream in 15-gram units. This contract, awarded on August 7, 2025, represents a firm fixed-price delivery order with an ultimate completion date of August 8, 2025. The award was not designated as a set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- SPE2DR25D7068Indefinite Delivery Contract
- SPE2DR25D7068-SPE2DR26F5BV1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,077.26 to AmerisourceBergen Drug Corp for Mupirocin 2% Ointment (22gm), with an ultimate completion date of December 8, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on December 5, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a leading pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support, enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The company's federal contracting demonstrates its capability to fulfill diverse medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 12/4/25 |